{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,23]],"date-time":"2026-08-23T16:23:24Z","timestamp":1787502204369,"version":"build-2736575974"},"reference-count":32,"publisher":"Public Library of Science (PLoS)","issue":"9","license":[{"start":{"date-parts":[[2022,9,8]],"date-time":"2022-09-08T00:00:00Z","timestamp":1662595200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001505","name":"New Zealand Health Research Council","doi-asserted-by":"crossref","award":["ID 14\/499"],"award-info":[{"award-number":["ID 14\/499"]}],"id":[{"id":"10.13039\/501100001505","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["www.plosmedicine.org"],"crossmark-restriction":false},"short-container-title":["PLoS Med"],"abstract":"\n Background<\/jats:title>\n Treatment for gestational diabetes mellitus (GDM) aims to reduce maternal hyperglycaemia. The TARGET Trial assessed whether tighter compared with less tight glycaemic control reduced maternal and perinatal morbidity.<\/jats:p>\n <\/jats:sec>\n \n Methods and findings<\/jats:title>\n \n In this stepped-wedge, cluster-randomised trial, identification number ACTRN12615000282583, 10 hospitals in New Zealand were randomised to 1 of 5 implementation dates. The trial was registered before the first participant was enrolled. All hospitals initially used less tight targets (fasting plasma glucose (FPG) <5.5 mmol\/L (<99 mg\/dL), 1-hour <8.0 mmol\/L (<144 mg\/dL), 2 hour postprandial <7.0 mmol\/L (<126 mg\/dL)) and every 4 months, 2 hospitals moved to use tighter targets (FPG \u22645.0 mmol\/L (\u226490 mg\/dL), 1-hour \u22647.4 mmol\/L (\u2264133 mg\/dL), 2 hour postprandial \u22646.7 mmol\/L) (\u2264121 mg\/dL). Women with GDM, blinded to the targets in use, were eligible. The primary outcome was large for gestational age. Secondary outcomes assessed maternal and infant health. Analyses were by intention to treat. Between May 2015 and November 2017, data were collected from 1,100 women with GDM (1,108 infants); 598 women (602 infants) used the tighter targets and 502 women (506 infants) used the less tight targets. The rate of large for gestational age was similar between the treatment target groups (88\/599, 14.7% versus 76\/502, 15.1%; adjusted relative risk [adjRR] 0.96, 95% confidence interval [CI] 0.66 to 1.40,\n P<\/jats:italic>\n = 0.839). The composite serious health outcome for the infant of perinatal death, birth trauma, or shoulder dystocia was apparently reduced in the tighter group when adjusted for gestational age at diagnosis of GDM, BMI, ethnicity, and history of GDM compared with the less tight group (8\/599, 1.3% versus 13\/505, 2.6%, adjRR 0.23, 95% CI 0.06 to 0.88,\n P<\/jats:italic>\n = 0.032). No differences were seen for the other infant secondary outcomes apart from a shorter stay in intensive care (\n P<\/jats:italic>\n = 0.041). Secondary outcomes for the woman showed an apparent increase for the composite serious health outcome that included major haemorrhage, coagulopathy, embolism, and obstetric complications in the tighter group (35\/595, 5.9% versus 15\/501, 3.0%, adjRR 2.29, 95% CI 1.14 to 4.59,\n P<\/jats:italic>\n = 0.020). There were no differences between the target groups in the risk for pre-eclampsia, induction of labour, or cesarean birth, but more women using tighter targets required pharmacological treatment (404\/595, 67.9% versus 293\/501, 58.5%, adjRR 1.20, 95% CI 1.00 to 1.44,\n P<\/jats:italic>\n = 0.047). The main study limitation is that the treatment targets used may vary to those in use in some countries.\n <\/jats:p>\n <\/jats:sec>\n \n Conclusions<\/jats:title>\n Tighter glycaemic targets in women with GDM compared to less tight targets did not reduce the risk of a large for gestational age infant, but did reduce serious infant morbidity, although serious maternal morbidity was increased. These findings can be used to aid decisions on the glycaemic targets women with GDM should use.<\/jats:p>\n <\/jats:sec>\n \n Trial registration<\/jats:title>\n \n The Australian New Zealand Clinical Trials Registry (ANZCTR).\n ACTRN12615000282583<\/jats:ext-link>\n .\n <\/jats:p>\n <\/jats:sec>","DOI":"10.1371\/journal.pmed.1004087","type":"journal-article","created":{"date-parts":[[2022,9,8]],"date-time":"2022-09-08T13:26:47Z","timestamp":1662643607000},"page":"e1004087","update-policy":"https:\/\/doi.org\/10.1371\/journal.pmed.corrections_policy","source":"Crossref","is-referenced-by-count":46,"title":["Tighter or less tight glycaemic targets for women with gestational diabetes mellitus for reducing maternal and perinatal morbidity: A stepped-wedge, cluster-randomised trial"],"prefix":"10.1371","volume":"19","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9079-4451","authenticated-orcid":true,"given":"Caroline A.","family":"Crowther","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Deborah","family":"Samuel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruth","family":"Hughes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6454-124X","authenticated-orcid":true,"given":"Thach","family":"Tran","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julie","family":"Brown","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0874-6654","authenticated-orcid":true,"given":"Jane M.","family":"Alsweiler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"name":"on behalf of the TARGET Study Group","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2022,9,8]]},"reference":[{"key":"pmed.1004087.ref001","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1002\/(SICI)1096-9136(199807)15:7<539::AID-DIA668>3.0.CO;2-S","article-title":"Definition, diagnosis and classification of diabetes mellitus. Part 1: diagnosis and classification of diabetes mellitus: World Health Organization Report","volume":"15","author":"K Alberti","year":"1998","journal-title":"Diabet Med"},{"key":"pmed.1004087.ref002","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1007\/s11892-015-0699-x","article-title":"Prevalence of gestational diabetes and risk of progression to Type 2 Diabetes: a global perspective.","volume":"16","author":"Y Zhu","year":"2016","journal-title":"Curr Diab Rep"},{"key":"pmed.1004087.ref003","doi-asserted-by":"crossref","first-page":"1991","DOI":"10.1056\/NEJMoa0707943","article-title":"Hyperglycaemia and adverse pregnancy outcomes","volume":"358","author":"HAPO Study Cooperative Research Group","year":"2008","journal-title":"N Engl J Med"},{"key":"pmed.1004087.ref004","doi-asserted-by":"crossref","first-page":"e290","DOI":"10.1542\/peds.2004-1808","article-title":"Metabolic syndrome in childhood: association with birth weight, maternal obesity, and gestational diabetes mellitus","volume":"115","author":"CM Boney","year":"2005","journal-title":"Pediatrics"},{"key":"pmed.1004087.ref005","doi-asserted-by":"crossref","first-page":"2477","DOI":"10.1056\/NEJMoa042973","article-title":"Effect of treatment of gestational diabetes mellitus on pregnancy outcomes.","volume":"352","author":"The Australian Carbohydrate Intolerance Study in Pregnant Women (ACHOIS) Trial Group","year":"2005","journal-title":"N Engl J Med"},{"key":"pmed.1004087.ref006","doi-asserted-by":"crossref","first-page":"1339","DOI":"10.1056\/NEJMoa0902430","article-title":"A multicentre, randomized trial of treatment for mild gestational diabetes","volume":"361","author":"M Landon","year":"2009","journal-title":"N Engl J Med"},{"key":"pmed.1004087.ref007","first-page":"nuab005","article-title":"Dietary recommendations for women with gestational diabetes mellitus: a systematic review of clinical practice guidelines.","author":"S Mustafa","year":"2021","journal-title":"Nutr Rev"},{"key":"pmed.1004087.ref008","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1016\/j.ajog.2004.06.059","article-title":"Diurnal glycemic profile in obese and normal weight non-diabetic pregnant women.","volume":"191","author":"Y Yogev","year":"2004","journal-title":"Am J Obstet Gynecol"},{"key":"pmed.1004087.ref009","doi-asserted-by":"crossref","first-page":"4319","DOI":"10.1210\/jc.2013-2461","article-title":"Glucose targets in pregnant women with diabetes: a systematic review and meta-analysis","volume":"98","author":"GJ Prutsky","year":"2013","journal-title":"J Clin Endocrinol Metab"},{"key":"pmed.1004087.ref010","article-title":"Different intensities of glycaemic control for women with gestational diabetes mellitus","volume":"4","author":"R Martis","year":"2016","journal-title":"Cochrane Database Syst Rev"},{"key":"pmed.1004087.ref011","first-page":"S55","article-title":"Gestational diabetes and glycemic control: a randomized clinical trial","volume":"178","author":"J Snyder","year":"1998","journal-title":"Am J Obstet Gynecol"},{"key":"pmed.1004087.ref012","doi-asserted-by":"crossref","first-page":"e64","DOI":"10.2337\/dc12-2345","article-title":"Testing for Gestational Diabetes Mellitus in Australia","volume":"36","author":"A Nankervis","year":"2013","journal-title":"Diabetes Care"},{"key":"pmed.1004087.ref013","unstructured":"Scottish Intercollegiate Guidelines Network. Management of diabetes. A national clinical guideline. Health Improvement Scotland March 2010. Updated November 2017. Healthcare Improvement Scotland, ISBN 978 1 905813 58 2."},{"key":"pmed.1004087.ref014","doi-asserted-by":"crossref","first-page":"S14","DOI":"10.2337\/dc20-S002","volume":"43","year":"2020","journal-title":"Diabetes Care"},{"key":"pmed.1004087.ref015","doi-asserted-by":"crossref","first-page":"4227","DOI":"10.1210\/jc.2013-2465","article-title":"Diabetes and Pregnancy: An Endocrine Society Clinical Practice Guideline","volume":"98","author":"I Blumer","year":"2013","journal-title":"J Clin Endocrinol Metab"},{"key":"pmed.1004087.ref016","volume-title":"Guideline for the screening, diagnosis and treatment of women with gestational diabetes in New Zealand.","author":"Ministry of Health","year":"2014"},{"key":"pmed.1004087.ref017","doi-asserted-by":"crossref","first-page":"93","DOI":"10.5694\/j.1326-5377.1998.tb140192.x","article-title":"Gestational diabetes mellitus: management guidelines. The Australasian Diabetes in Pregnancy Society.","volume":"169","author":"L Hoffman","year":"1998","journal-title":"Med J Aust"},{"key":"pmed.1004087.ref018","doi-asserted-by":"crossref","first-page":"676","DOI":"10.2337\/dc09-1848","article-title":"International Association of Diabetes and Pregnancy Study Groups recommendations on the diagnosis and classification of hyperglycemia in pregnancy.","volume":"33","author":"IADPSG Consensus Panel","year":"2010","journal-title":"Diabetes Care"},{"issue":"3","key":"pmed.1004087.ref019","doi-asserted-by":"crossref","first-page":"1043","DOI":"10.1093\/ije\/dyaa077","article-title":"Reflection on modern methods: when is a stepped-wedge cluster randomized trial a good study design choice?","volume":"49","author":"K Hemming","year":"2020","journal-title":"Int J Epidemiol"},{"key":"pmed.1004087.ref020","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1186\/s12884-018-2060-2","article-title":"Tight or less tight glycaemic targets for women with gestational diabetes mellitus for reducing maternal and perinatal morbidity? (TARGET): study protocol.","volume":"18","author":"Target Study Group.","year":"2018","journal-title":"BMC Pregnancy Childbirth"},{"key":"pmed.1004087.ref021","doi-asserted-by":"crossref","first-page":"k1614","DOI":"10.1136\/bmj.k1614","article-title":"Reporting of stepped wedge cluster randomised trials: extension of the CONSORT 2010 statement with explanation and elaboration","volume":"363","author":"K Hemming","year":"2018","journal-title":"BMJ"},{"issue":"1","key":"pmed.1004087.ref022","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1471-2431-13-59","article-title":"A systematic review and meta-analysis to revise the Fenton growth charts for preterm infants","volume":"13","author":"TR Fenton","year":"2013","journal-title":"BMC Pediatr"},{"key":"pmed.1004087.ref023","doi-asserted-by":"crossref","first-page":"1796","DOI":"10.1056\/NEJMoa054186","article-title":"ACTS Study Group. Vitamins C and E and the risks of preeclampsia and perinatal complications","volume":"354","author":"AR Rumbold","year":"2006","journal-title":"N Engl J Med"},{"key":"pmed.1004087.ref024","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1016\/j.cct.2006.05.007","article-title":"Design and analysis of stepped wedge cluster randomized trials.","volume":"28","author":"M Hussey","year":"2007","journal-title":"Contemp Clin Trials"},{"key":"pmed.1004087.ref025","unstructured":"Committee for medicinal products for human use (CHMP) Guideline on Adjustment for Baseline Covariates in Clinical Trials 2015. Available from: https:\/\/www.ema.europa.eu\/en\/documents\/scientific-guideline\/guideline-adjustment-baseline-covariates-clinical-trials_en.pdf."},{"issue":"5","key":"pmed.1004087.ref026","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1016\/j.cct.2010.07.005","article-title":"Estimating adjusted NNTs in randomised controlled trials with binary outcomes: a simulation study.","volume":"31","author":"R Bender","year":"2010","journal-title":"Contemp Clin Trials"},{"issue":"23","key":"pmed.1004087.ref027","doi-asserted-by":"crossref","first-page":"3670","DOI":"10.1002\/sim.7348","article-title":"Bias and inference from misspecified mixed-effect models in stepped wedge trial analysis.","volume":"36","author":"JA Thompson","year":"2017","journal-title":"Stat Med"},{"key":"pmed.1004087.ref028","doi-asserted-by":"crossref","first-page":"804","DOI":"10.1067\/mpd.2001.118887","article-title":"Beneficial effects of intensive therapy of diabetes during adolescence: Outcomes after the conclusion of the Diabetes Control and Complications Trial (DCCT).","volume":"139","author":"The Diabetes Control and Complications Trial\/Epidemiology of Diabetes Interventions and Complications Research Group","year":"2001","journal-title":"J Pediatr"},{"key":"pmed.1004087.ref029","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1016\/S0140-6736(98)07019-6","article-title":"Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33).","volume":"352","author":"UK Prospective Diabetes Study (UKPDS) Group","year":"1998","journal-title":"Lancet"},{"key":"pmed.1004087.ref030","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1542\/peds.2011-2470","article-title":"Tight glycemic control with insulin in hyperglycemic preterm babies: a randomized controlled trial","volume":"129","author":"JM Alsweiler","year":"2012","journal-title":"Pediatrics"},{"key":"pmed.1004087.ref031","article-title":"Randomized controlled trial of different intensities of glycemic control in women with gestational diabetes.","author":"P Popova","year":"2020","journal-title":"22nd European Society of Endocrinology."},{"key":"pmed.1004087.ref032","doi-asserted-by":"crossref","first-page":"100050","DOI":"10.1016\/j.ajogmf.2019.100050","article-title":"Intensive glycemic control in gestational diabetes mellitus: a randomized controlled clinical feasibility trial","volume":"1","author":"CM Scifres","year":"2019","journal-title":"Am J Obstet Gynecol MFM"}],"container-title":["PLOS Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pmed.1004087","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,9,8]],"date-time":"2022-09-08T13:27:35Z","timestamp":1662643655000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pmed.1004087"}},"subtitle":[],"editor":[{"given":"Jenny E.","family":"Myers","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2022,9,8]]},"references-count":32,"journal-issue":{"issue":"9","published-online":{"date-parts":[[2022,9,8]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pmed.1004087","relation":{},"ISSN":["1549-1676"],"issn-type":[{"value":"1549-1676","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,9,8]]}}}